9. Mao JH，Sun XY，Liu JX，Zhang QY，Liu P，Huang QH，Li KK，Chen Q，Chen Z，Chen SJ. As4S4 targets RING-type E3 ligase c-CBL to induce degradation of BCR-ABL in chronic myelogenous leukemia. Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):-8.

10. Zhao LJ，Wang YY，Li G，Ma LY，Xiong SM，Weng XQ，Zhang WN，Wu B，Chen Z，Chen SJ. Functional features of RUNX1 mutants in acute transformation of chronic myeloid leukemia and their contribution to inducing murine full-blown leukemia. Blood. 2012 Mar 22;119(12):2873-82.

11. Chen SJ，Zhou GB，Zhang XW，Mao JH，de Thé H，Chen Z. From an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemia. Blood. 2011 Jun 16;117(24):6425-37.

12. Zhou GB，Li G，Chen SJ，Chen Z. From dissection of disease pathogenesis to elucidation of mechanisms of targeted therapies:leukemia research in the genomic era. Acta Pharmacol Sin. 2007 Sep;28(9):1434-49.

13. Hu J，Zhou GB，Wang ZY，Chen SJ，Chen Z. Mutant transcription factors and tyrosine kinases as therapeutic targets for leukemias: from acute promyelocytic leukemia to chronic myeloid leukemia and beyond. Adv Cancer Res. 2007;98:191-220.

14. Zhou GB，Zhang J，Wang ZY，Chen SJ，Chen Z. Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy. Philos Trans R Soc Lond B Biol Sci. 2007 Jun 29;362(1482):959-71.

15. Hu J，Liu YF，Wu CF，Xu F，Shen ZX，Zhu YM，Li JM，Tang W，Zhao WL，Wu W，Sun HP， Chen QS，Chen B，Zhou GB，Zelent A，Waxman S，Wang ZY，Chen SJ，Chen Z. Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia. Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3342-7.

16. Zhou GB，Zhao WL，Wang ZY，Chen SJ，Chen Z. Retinoic acid and arsenic for treating acute promyelocytic leukemia. PLoS Med. 2005 Jan;2(1):e12.

17. Fang J，Chen SJ，Tong JH，Wang ZG，Chen GQ，Chen Z. Treatment of acute promyelocytic leukemia with ATRA and As2O3:a model of molecular target-based cancer therapy. Cancer Biol Ther. 2002 Nov-Dec;1(6):614-20.

18. Zhang QY，Mao JH，Liu P，Huang QH，Lu J，Xie YY，Weng L，Zhang Y，Chen Q，Chen SJ， Chen Z. A systems biology understanding of the synergistic effects of arsenic sulfide and Imatinib in BCR/ABL-associated leukemia. Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3378-83.

19. Zhou GB，Chen SJ，Chen Z. Acute promyelocytic leukemia:a model of molecular target based therapy. Hematology. 2005;10 Suppl 1:270-80.

20. Chen LJ，Dong Y，Chen SY，Zhang L，Zhou GB，Chen B，Wang L，Chen Z，Chen SJ. hCG-PLZF-RARalpha/hCG-RARalpha-PLZF transgenic mice developing into leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005 Dec;13(6):924-31.

21. Hu Z，Pan XF，Wu FQ，Ma LY，Liu DP，Liu Y，Feng TT，Meng FY，Liu XL，Jiang QL，Chen XQ，Liu JL，Liu P，Chen Z，Chen SJ，Zhou GB. Synergy between proteasome inhibitors and imatinib mesylate in chronic myeloid leukemia. PLoS One. 2009 Jul 16;4(7):e6257.

22. Liu H，Chen B，Xiong H，Huang QH，Zhang QH，Wang ZG，Li BL，Chen Z，Chen SJ. Functional contribution of EEN to leukemogenic transformation by MLL-EEN fusion protein. Oncogene. 2004 Apr 22;23(19):3385-94.

23. Shen Y，Zhu YM，Fan X，Shi JY，Wang QR，Yan XJ，Gu ZH，Wang YY，Chen B，Jiang CL， Yan H，Chen FF，Chen HM，Chen Z，Jin J，Chen SJ. Gene mutation patterns and their prognostic impact in a cohort of 1185 patients with acute myeloid leukemia. Blood. 2011 Nov 17;118(20):5593-603.

24. Zhang SJ，Ma LY，Huang QH，Li G，Gu BW，Gao XD，Shi JY，Wang YY，Gao L，Cai X，Ren RB，Zhu J，Chen Z，Chen SJ. Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia. Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2076-81.

25. Jiang LJ，Zhang NN，Ding F，Li XY，Chen L，Zhang HX，Zhang W，Chen SJ，Wang ZG， Li JM，Chen Z，Zhu J. RA-inducible gene-I induction augments STAT1 activation to inhibit leukemia cell proliferation. Proc Natl Acad Sci U S A. 2011 Feb 1;108(5):1897-902.

26. Shi JY，Ren ZH，Jiao B，Xiao R，Yun HY，Chen B，Zhao WL，Zhu Q，Chen Z，Chen SJ. Genetic variations of DNA repair genes and their prognostic significance in patients with acute myeloid leukemia. Int J Cancer. 2011 Jan 1;128(1):233-8.

27. Zhang QY，Huang QH，Shen SH，Wang HH，Chen SJ，Chen Z. Influence of different conditions on two-dimensional gel electrophoresis of proteins from human acute promyelocytic leukemia cell line NB4. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2004 Aug;12(4):401-5. Chinese

28. Yin T，Wu YL，Sun HP，Sun GL，Du YZ，Wang KK，Zhang J，Chen GQ，Chen SJ，Chen Z. Combined effects of As4S4 and imatinib on chronic myeloid leukemia cells and BCR-ABL oncoprotein. Blood. 2004 Dec 15;104(13):4219-25.

29. Jia PM，Zhu Q，Yu Y，Chen GQ，Chen SJ，Chen Z，Wang ZY，Tong JH. Experimental study of low dose arsenic trioxide in treatment of patients with acute promyelocytic leukemia. Ai Zheng. 2002 Apr;21(4):337-40. Chinese

文章来源：《中国实验血液学杂志》 网址: http://www.zgsyxyxzz.cn/zonghexinwen/2020/0909/426.html